Study Supports Long-Term Efficacy of Esketamine Nasal Spray in Patients with ESRD
CONFERENCE REPORTER Results from a recent study showed that flexible-dosing esketamine nasal spray demonstrated sustained improvements in depressive symptoms in adults with treatment-resistant depression (TRD) for up to 6.5 years. Study investigators shared these results in a poster presentation at Psych Congress 2023. The poster presentation, titled Long-Term Efficacy of Esketamine Nasal Spray Dosed According … Read more